Home About Us Pipeline News Investors Contacts Careers

STOCK INFORMATION

FEATURED PRESS RELEASE

  • 8/11/14 1:10 pm PDT
    LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc. (NYSE: PBYI), a development stage biopharmaceutical company, announced financial results for the second quarter ended June 30, 2014. Unless otherwise stated, all comparisons are for the second quarter and first half of the year 2014 compared to the second quarter and first half of the year 2013. Based on accounting principles generally accepted in the United States (GAAP), Puma reported a netmore...

SEARCH INVESTOR RELATIONS

CONTACTS

Puma Biotechnology, Inc.
10880 Wilshire Blvd., Suite 2150
Los Angeles, CA 90024
424-248-6500 Main
424-248-6501 Fax

ir@pumabiotechnology.com